Literature DB >> 34165714

An Overview of the Computational Models Dealing with the Regulatory ceRNA Mechanism and ceRNA Deregulation in Cancer.

Federica Conte1, Giulia Fiscon1,2, Pasquale Sibilio1,3, Valerio Licursi4, Paola Paci5,6.   

Abstract

Pools of RNA molecules can act as competing endogenous RNAs (ceRNAs) and indirectly alter their expression levels by competitively binding shared microRNAs. This ceRNA cross talk yields an additional posttranscriptional regulatory layer, which plays key roles in both physiological and pathological processes. MicroRNAs can act as decoys by binding multiple RNAs, as well as RNAs can act as ceRNAs by competing for binding multiple microRNAs, leading to many cross talk interactions that could favor significant large-scale effects in spite of the weakness of single interactions. Identifying and studying these extended ceRNA interaction networks could provide a global view of the fine-tuning gene regulation in a wide range of biological processes and tumor progressions. In this chapter, we review current progress of predicting ceRNA cross talk, by summarizing the most up-to-date databases, which collect computationally predicted and/or experimentally validated miRNA-target and ceRNA-ceRNA interactions, as well as the widespread computational methods for discovering and modeling possible evidences of ceRNA-ceRNA interaction networks. These methods can be grouped in two categories: statistics-based methods exploit multivariate analysis to build ceRNA networks, by considering the miRNA expression levels when evaluating miRNA sponging relationships; mathematical methods build deterministic or stochastic models to analyze and predict the behavior of ceRNA cross talk.

Entities:  

Keywords:  Cancer; Competing endogenous RNA; Network

Year:  2021        PMID: 34165714     DOI: 10.1007/978-1-0716-1503-4_10

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  31 in total

1.  An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma.

Authors:  Pavel Sumazin; Xuerui Yang; Hua-Sheng Chiu; Wei-Jen Chung; Archana Iyer; David Llobet-Navas; Presha Rajbhandari; Mukesh Bansal; Paolo Guarnieri; Jose Silva; Andrea Califano
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 2.  Non-coding RNAs, epigenetics and complexity.

Authors:  Fabrício F Costa
Journal:  Gene       Date:  2008-01-15       Impact factor: 3.688

3.  Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma.

Authors:  Liang Yang; Xueqiang Peng; Hongyuan Jin; Jingang Liu
Journal:  Gene       Date:  2019-02-20       Impact factor: 3.688

4.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

5.  LincRNA-p21 suppresses target mRNA translation.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Subramanya Srikantan; Xiaoling Yang; Jennifer L Martindale; Supriyo De; Maite Huarte; Ming Zhan; Kevin G Becker; Myriam Gorospe
Journal:  Mol Cell       Date:  2012-07-26       Impact factor: 17.970

6.  MicroRNAs can generate thresholds in target gene expression.

Authors:  Shankar Mukherji; Margaret S Ebert; Grace X Y Zheng; John S Tsang; Phillip A Sharp; Alexander van Oudenaarden
Journal:  Nat Genet       Date:  2011-08-21       Impact factor: 38.330

7.  A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.

Authors:  Laura Poliseno; Leonardo Salmena; Jiangwen Zhang; Brett Carver; William J Haveman; Pier Paolo Pandolfi
Journal:  Nature       Date:  2010-06-24       Impact factor: 49.962

Review 8.  PVT1: a rising star among oncogenic long noncoding RNAs.

Authors:  Teresa Colombo; Lorenzo Farina; Giuseppe Macino; Paola Paci
Journal:  Biomed Res Int       Date:  2015-03-26       Impact factor: 3.411

9.  Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs.

Authors:  Shuo Gu; Lan Jin; Feijie Zhang; Peter Sarnow; Mark A Kay
Journal:  Nat Struct Mol Biol       Date:  2009-02-01       Impact factor: 15.369

10.  Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer.

Authors:  Paola Paci; Teresa Colombo; Lorenzo Farina
Journal:  BMC Syst Biol       Date:  2014-07-17
View more
  8 in total

1.  The regulatory mechanism of LncRNA-mediated ceRNA network in osteosarcoma.

Authors:  Chengsen Lin; Jifeng Miao; Shijie Liao; Yun Liu; Juliang He; Wenyu Feng; Xianxiang Chen; Xiaohong Jiang; Jianhong Liu; Boxiang Li; Qian Huang
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

2.  Construction and analysis of a ceRNA network and patterns of immune infiltration in chronic rhinosinusitis with nasal polyps: based on data mining and experimental verification.

Authors:  Jing-Cai Chen; Qi-Long Xing; Hui-Wen Yang; Fan Yang; Yao Luo; Wei-Jia Kong; Yan-Jun Wang
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

3.  ncRNA-Mediated High Expression of LPCAT1 Correlates with Poor Prognosis and Tumor Immune Infiltration of Liver Hepatocellular Carcinoma.

Authors:  Qiu Sun; Xudong Liu; Qunlong Peng; Lei Hu; Xiaochun Jiang
Journal:  J Immunol Res       Date:  2022-05-16       Impact factor: 4.493

Review 4.  Pseudogene Transcripts in Head and Neck Cancer: Literature Review and In Silico Analysis.

Authors:  Juliana Carron; Rafael Della Coletta; Gustavo Jacob Lourenço
Journal:  Genes (Basel)       Date:  2021-08-17       Impact factor: 4.096

5.  YY1-induced long non-coding RNA small nucleolar RNA host gene 8 promotes the tumorigenesis of melanoma via the microRNA-656-3p/SERPINE1 mRNA binding protein 1 axis.

Authors:  Baihui Shan; Shengming Qu; Sha Lv; Dandan Fan; Shu Wang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

6.  CircMYC promotes proliferation, migration, invasion and inhibits apoptosis of small cell lung cancer by targeting miR-145/ Matrix Metallopeptidase 2 axis.

Authors:  Xi Yang; Lianqin Tao; Yani Xu; Sujian Li; Weiwei Yang; Lijuan Wang; Junfei Zhu
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

7.  Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.

Authors:  Xiaoling Gao; Wenhao Zhang; Yanjuan Jia; Hui Xu; Yuchen Zhu; Xiong Pei
Journal:  Sci Rep       Date:  2022-09-28       Impact factor: 4.996

8.  LncRNA CARMN Affects Hepatocellular Carcinoma Prognosis by Regulating the miR-192-5p/LOXL2 Axis.

Authors:  Xiaokang Wang; Shulong Wu; Yi Yang; Jingjing Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-10-08       Impact factor: 7.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.